-
Je něco špatně v tomto záznamu ?
Longer-term outcomes after bicuspid aortic valve repair in 142 patients
M. Safari, N. Monsefi, A. Karimian-Tabrizi, A. Miskovic, A. Van Linden, P. Zacek, A. Moritz, T. Walther, T. Holubec
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
Grantová podpora
The study was supported by the Grant Agency of Charles University Progress Q40/4.
NLK
Medline Complete (EBSCOhost)
od 2003-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1986
PubMed
34547142
DOI
10.1111/jocs.16006
Knihovny.cz E-zdroje
- MeSH
- aortální chlopeň chirurgie MeSH
- aortální insuficience * chirurgie MeSH
- bikuspidální aortální chlopeň * MeSH
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- nemoci srdečních chlopní * chirurgie MeSH
- reoperace MeSH
- retrospektivní studie MeSH
- výsledek terapie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND: The aim of this study was to evaluate the longer-term results of bicuspid aortic valve (BAV) repair with or without aortic root replacement. METHODS: From 1999 to 2017, 142 patients with or without aortic root dilatation who underwent repair of a regurgitant BAV were included in the study. Ninety-four patients underwent isolated BAV repair (Group 1; median age 43 years) and 48 patients underwent valve-sparing aortic root replacement plus BAV repair (aortic valve reimplantation-Group 2; median age 48 years). Median clinical follow-up time was 5.9 years (range 0.5-15) in Group 1 and 3 years (range 0.5-16) in Group 2, respectively. RESULTS: In-hospital mortality was 1% in Group 1, and 2% in Group 2 (p = .6). The 5- and 10-year survival was 93 ± 2.9% and 81 ± 5.8% in Group 1 and 96 ± 3.1% and 96 ± 3.1% in Group 2, respectively (p = .31). Eleven patients of Group 1 (1.7%/patient-year) and five patients of Group 2 (2.2%/patient-year) underwent reoperation of the aortic valve (p = .5). The 5- and 10-year freedom from reoperation were 93.0 ± 2.1% and 77.1 ± 7.1% in Group 1 and 93.0 ± 5.0% and 76.7 ± 9.6% in Group 2 (p = .83), respectively. At the latest follow-up, only two patients of Group 1 and 1 patient of Group 2 had AV regurgitation = 2° (p = .7). The cumulative linearized incidence of all valve-related complications (bleeding, stroke, endocarditis, and reoperation) was 2.9%/patient-year in Group 1% and 4%/patient-year in Group 2, respectively (p = .6). CONCLUSIONS: Isolated BAV repair and combined aortic valve reimplantation plus BAV repair provide good clinical longer-term outcomes with relatively low reoperation rate and durable valve function.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22003110
- 003
- CZ-PrNML
- 005
- 20220127150650.0
- 007
- ta
- 008
- 220113s2021 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/jocs.16006 $2 doi
- 035 __
- $a (PubMed)34547142
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Safari, Mojyan $u Department of Cardiovascular Surgery, University Hospital Frankfurt and Johann Wolfgang Goethe University Frankfurt, Frankfurt, Germany
- 245 10
- $a Longer-term outcomes after bicuspid aortic valve repair in 142 patients / $c M. Safari, N. Monsefi, A. Karimian-Tabrizi, A. Miskovic, A. Van Linden, P. Zacek, A. Moritz, T. Walther, T. Holubec
- 520 9_
- $a BACKGROUND: The aim of this study was to evaluate the longer-term results of bicuspid aortic valve (BAV) repair with or without aortic root replacement. METHODS: From 1999 to 2017, 142 patients with or without aortic root dilatation who underwent repair of a regurgitant BAV were included in the study. Ninety-four patients underwent isolated BAV repair (Group 1; median age 43 years) and 48 patients underwent valve-sparing aortic root replacement plus BAV repair (aortic valve reimplantation-Group 2; median age 48 years). Median clinical follow-up time was 5.9 years (range 0.5-15) in Group 1 and 3 years (range 0.5-16) in Group 2, respectively. RESULTS: In-hospital mortality was 1% in Group 1, and 2% in Group 2 (p = .6). The 5- and 10-year survival was 93 ± 2.9% and 81 ± 5.8% in Group 1 and 96 ± 3.1% and 96 ± 3.1% in Group 2, respectively (p = .31). Eleven patients of Group 1 (1.7%/patient-year) and five patients of Group 2 (2.2%/patient-year) underwent reoperation of the aortic valve (p = .5). The 5- and 10-year freedom from reoperation were 93.0 ± 2.1% and 77.1 ± 7.1% in Group 1 and 93.0 ± 5.0% and 76.7 ± 9.6% in Group 2 (p = .83), respectively. At the latest follow-up, only two patients of Group 1 and 1 patient of Group 2 had AV regurgitation = 2° (p = .7). The cumulative linearized incidence of all valve-related complications (bleeding, stroke, endocarditis, and reoperation) was 2.9%/patient-year in Group 1% and 4%/patient-year in Group 2, respectively (p = .6). CONCLUSIONS: Isolated BAV repair and combined aortic valve reimplantation plus BAV repair provide good clinical longer-term outcomes with relatively low reoperation rate and durable valve function.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a aortální chlopeň $x chirurgie $7 D001021
- 650 12
- $a aortální insuficience $x chirurgie $7 D001022
- 650 12
- $a bikuspidální aortální chlopeň $7 D000082882
- 650 12
- $a nemoci srdečních chlopní $x chirurgie $7 D006349
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a reoperace $7 D012086
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Monsefi, Nadejda $u Department of Cardiac Surgery, University Hospital Bonn, Bonn, Germany
- 700 1_
- $a Karimian-Tabrizi, Afsaneh $u Department of Cardiovascular Surgery, University Hospital Frankfurt and Johann Wolfgang Goethe University Frankfurt, Frankfurt, Germany
- 700 1_
- $a Miskovic, Alexandra $u Department of Cardiovascular Surgery, University Hospital Frankfurt and Johann Wolfgang Goethe University Frankfurt, Frankfurt, Germany
- 700 1_
- $a Van Linden, Arnaud $u Department of Cardiovascular Surgery, University Hospital Frankfurt and Johann Wolfgang Goethe University Frankfurt, Frankfurt, Germany
- 700 1_
- $a Zacek, Pavel $u Department of Cardiac Surgery, Faculty of Medicine in Hradec Kralove, University Hospital Hradec Kralove and Charles University, Hradec Kralove, Czech Republic
- 700 1_
- $a Moritz, Anton $u Department of Cardiovascular Surgery, University Hospital Frankfurt and Johann Wolfgang Goethe University Frankfurt, Frankfurt, Germany
- 700 1_
- $a Walther, Thomas $u Department of Cardiovascular Surgery, University Hospital Frankfurt and Johann Wolfgang Goethe University Frankfurt, Frankfurt, Germany
- 700 1_
- $a Holubec, Tomas $u Department of Cardiovascular Surgery, University Hospital Frankfurt and Johann Wolfgang Goethe University Frankfurt, Frankfurt, Germany
- 773 0_
- $w MED00002566 $t Journal of cardiac surgery $x 1540-8191 $g Roč. 36, č. 12 (2021), s. 4645-4651
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34547142 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20220127150646 $b ABA008
- 999 __
- $a ok $b bmc $g 1750775 $s 1154259
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 36 $c 12 $d 4645-4651 $e 20210921 $i 1540-8191 $m Journal of cardiac surgery $n J Card Surg $x MED00002566
- GRA __
- $p The study was supported by the Grant Agency of Charles University Progress Q40/4.
- LZP __
- $a Pubmed-20220113
